These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TECOGEN INC.
|
|
(Name of Registrant as Specified in its Charter)
|
|
|
|
(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)
|
|
(3)
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
1.
|
To elect six directors to the Board of Directors of the Company to hold office for one year until the 2016 annual meeting or until their successors are duly elected and qualified.
|
|
2.
|
To approve the non-binding advisory vote on executive compensation ("say-on-pay").
|
|
3.
|
To approve the non-binding advisory vote on the frequency of future advisory votes on executive compensation.
|
|
4.
|
To ratify the appointment of Wolf & Company, P.C. as the Company's independent registered public accounting firm.
|
|
5.
|
To transact any other business which may properly be brought before the Annual Meeting or any adjournment or postponement thereof.
|
|
By Order of the Board of Directors,
|
|
TECOGEN INC
|
|
/s/ David A. Garrison
|
|
David A. Garrison
|
|
Secretary
|
|
1.
|
The election of six directors to the Board of Directors of the Company to hold office for one year or until their successors are duly elected and qualified, each as identified below;
|
|
2.
|
To approve a non-binding advisory vote on executive compensation ("say-on-pay").
|
|
3.
|
To approve a non-binding advisory vote on the frequency of future advisory votes on executive compensation every three years ("say-on-pay" frequency).
|
|
4.
|
The ratification of the appointment of Wolf & Company, P.C. as the Company's independent registered public accounting firm;
|
|
5.
|
The authorization to adjourn the Annual Meeting to a later date or dates if there are insufficient votes to approve the proposals; and
|
|
(1)
|
Electronically over the Internet as outlined in the Notice of Internet Availability; or
|
|
(2)
|
By requesting, completing and submitting a properly signed paper proxy card as outlined in the Notice of Internet Availability.
|
|
1.
|
FOR
the election of each of our Board’s nominees for director
;
|
|
2.
|
FOR
the approval of a non-binding, advisory proposal approving the Company's executive compensation ("say-on-pay")
.
|
|
3.
|
FOR
the approval of the non-binding, advisory vote on the frequency of future advisory votes on executive compensation every three years ("say-on-pay" frequency)
.
|
|
4.
|
FOR
the ratification of the appointment of Wolf & Company, P.C. as the Company's independent registered public accounting firm; and
|
|
5.
|
FOR
the authorization to adjourn the Annual Meeting to a later date or dates if there are insufficient votes present in person or represented by proxy at the Annual Meeting to approve the proposals.
|
|
1.
|
You may send in another proxy with a later date.
|
|
2.
|
You may notify the Company in writing (by you or your attorney authorized in writing, or if the stockholder is a corporation, under its corporate seal, by an officer or attorney of the corporation) at our principal executive offices before the Annual Meeting, that you are revoking your proxy.
|
|
3.
|
You may vote in person at the Annual Meeting.
|
|
Name
|
Age
|
Position(s)
|
(1)
|
(2)
|
(3)
|
|
Angelina M. Galiteva
|
48
|
Chairperson of the Board and Director
|
x
|
x
|
|
|
John N. Hatsopoulos
|
81
|
Co-Chief Executive Officer and Director
|
|
|
|
|
Benjamin M. Locke
|
47
|
Co-Chief Executive Officer
|
|
|
|
|
Robert A. Panora
|
60
|
Chief Operating Officer and President
|
|
|
|
|
David A. Garrison
|
47
|
Chief Financial Officer, Treasurer and Secretary
|
|
|
|
|
Joseph E. Aoun
|
62
|
Director
|
|
x
|
x
|
|
Ahmed F. Ghoniem
|
63
|
Director
|
x
|
x
|
x
|
|
Earl R. Lewis
|
71
|
Director
|
|
|
|
|
Charles T. Maxwell
|
83
|
Director
|
x
|
|
x
|
|
|
|
|
|
|
|
|
(1) Member of Audit Committee
|
|
|
|
||
|
(2) Member of Compensation Committee
|
|
|
|
||
|
(3) Member of the Nominating and Governance Committee
|
|
|
|
||
|
Name and Address of Beneficial Owner
|
|
Common Stock Beneficially Owned
(1)
|
|
Percent of Class
(1)
|
|
|
John N. Hatsopoulos
(2)
|
|
3,718,939
|
|
|
22.8%
|
|
George N. Hatsopoulos
(3)
|
|
3,554,651
|
|
|
21.8%
|
|
Joseph J. Ritchie
(4)
|
|
896,613
|
|
|
5.5%
|
|
Michaelson Capital Special Finance Fund LP
(5)
|
|
862,885
|
|
|
5.3%
|
|
(1)
|
Unless otherwise noted in these footnotes, the Company believes that all shares referenced in this table are owned of record by each person named as beneficial owner and that each person has sole voting and dispositive power with respect to the shares of Common Stock owned by each of them.
|
|
(2)
|
This information is as of December 31, 2014 and is based solely on a Schedule 13G filed by John N. Hatsopoulos with the SEC on February 18, 2015, or the John Hatsopoulos Schedule 13G”). In accordance with the disclosures set forth in the John Hatsopoulos Schedule 13G, John Hatsopoulos reports sole voting power over 2,135,210 shares, sole dispositive power over 2,135,210 shares, shared voting power over 1,583,729 shares and shared dispositive power over 1,583,129 shares. The percent owned is based on the calculation provided by John Hatsopoulos in the John Hatsopoulos Schedule 13G. Based on the information provided in the John Hatsopoulos Schedule 13G, the address of John Hatsopoulos is c/o Tecogen Inc., 45 First Avenue, Waltham, MA 02451.
|
|
(3)
|
This information is as of December 31, 2014 and is based solely on a Schedule 13G filed by George N. Hatsopoulos with the SEC on February 18, 2015, or the George Hatsopoulos Schedule 13G. In accordance with the disclosures set forth in the George Hatsopoulos Schedule 13G, George Hatsopoulos reports sole voting power over 2,250,000 shares, sole dispositive power over 2,250,000 shares, shared voting power over 1,304,651 shares and shared dispositive power over 1,304,651 shares. The percent owned is based on the calculation provided by George Hatsopoulos in the George Hatsopoulos Schedule 13G. Based on the information provided in the George Hatsopoulos Schedule 13G, the address of George Hatsopoulos is c/o Tecogen Inc., 45 First Avenue, Waltham, MA 02451.
|
|
(4)
|
This information is as of December 31, 2014 and is based solely on a Schedule 13G filed by Joseph L. Ritchie with the SEC on February 18, 2015, or the Ritchie Schedule 13G. In accordance with the disclosures set forth in the Ritchie Schedule 13G, Joseph Ritchie reports sole voting power over 896,613 shares and sole dispositive power over 896,613 shares. The percent owned is based on the calculation provided by Joseph Ritchie in the Ritchie Schedule 13G. Based on the information provided in the Ritchie Schedule 13G, the address of Joseph Ritchie is 2100 Enterprise Avenue, Geneva, IL 60134.
|
|
(5)
|
This information is as of December 31, 2014 and is based solely on a Schedule 13G filed by Michaelson Capital Special Finance Fund LP with the SEC on February 23, 2015, or the “Michaelson Schedule 13G. In accordance with the disclosures set forth in the Michaelson Schedule 13G, Michaelson Capital Special Finance Fund LP reports shared voting power over 862,885 shares and shared dispositive power over 862,885 shares. The percent owned is based on the calculation provided by Michaelson Capital Special Finance Fund LP in the Michaelson Schedule 13G. Based on the information provided in the Michaelson Schedule 13G, the address of Michaelson Capital Special Finance Fund LP is 400 Madison Avenue, Suite 2A, New York, NY 10017.
|
|
Name and address of beneficial owner
(1)
|
|
Amount and Nature of Beneficial Ownership
(2)
|
|
Percent of Class
(3)
|
||
|
John N. Hatsopoulos
(4)
|
|
3,718,939
|
|
|
22.8
|
%
|
|
Robert A. Panora
(5)
|
|
288,350
|
|
|
1.8
|
%
|
|
Charles T. Maxwell
(6)
|
|
100,000
|
|
|
*%
|
|
|
Angelina M. Galiteva
(7)
|
|
75,000
|
|
|
*%
|
|
|
Ahmed F. Ghoniem
(8)
|
|
50,000
|
|
|
*%
|
|
|
David A. Garrison
(9)
|
|
21,000
|
|
|
*%
|
|
|
Benjamin Locke
(10)
|
|
18,750
|
|
|
*%
|
|
|
Joseph E. Aoun
(11)
|
|
6,250
|
|
|
*%
|
|
|
Earl Lewis
|
|
—
|
|
|
*%
|
|
|
All executive officers and directors as a group (8 persons)
|
|
4,278,289
|
|
|
25.8
|
%
|
|
*
|
Designates less than 1% of beneficial ownership.
|
|
(1)
|
Unless otherwise specified, the address of each of our directors, nominees for directors, Named Executive Officers and executive officers is c/o Tecogen Inc., 45 First Avenue, Waltham, MA 02451.
|
|
(2)
|
In accordance with Rule 13d-3 under the Exchange Act, each person’s percentage ownership is determined by assuming that the options that are held by that person, and which are exercisable within 60 days, have been exercised.
|
|
(3)
|
Number of outstanding shares as of the Record Date and used in the calculation of percent of class is
16,338,782
.
|
|
(4)
|
Includes:(a) 2,135,210 shares of Common Stock held by J&P Enterprises LLC for the benefit of: (1) John N. Hatsopoulos and (2) Patricia L. Hatsopoulos. John N. Hatsopoulos is the Executive Member of J&P Enterprises LLC and has voting and investment power; (b) 593,770 shares of Common Stock held by John N. Hatsopoulos and his wife, Patricia L. Hatsopoulos, as joint tenants with rights of survivorship, each of whom share voting and investment power; (c) 989,859 shares of Common Stock held by The John N. Hatsopoulos Family Trust 2007 for the benefit of: (1) Patricia L. Hatsopoulos, (2) Alexander J. Hatsopoulos, and (3) Nia Marie Hatsopoulos, for which George N. Hatsopoulos and Patricia L. Hatsopoulos are the trustees; and (d) 100 shares of Common Stock held by Patricia L. Hatsopoulos, John N. Hatsopoulos's wife.
|
|
(5)
|
Includes: (a)
163,350
shares of Common Stock, directly held by Mr. Panora, and (b) options to purchase
125,000
shares of Common Stock exercisable within 60 days of
April 30, 2015
.
|
|
(6)
|
Includes: (a)
75,000
shares of Common Stock, directly held by Mr. Maxwell, and (b) options to purchase
25,000
shares of Common Stock exercisable within 60 days of
April 30, 2015
.
|
|
(7)
|
Includes: (a)
50,000
shares of Common Stock, directly held by Ms. Galiteva and (b) options to purchase
25,000
shares of Common Stock exercisable within 60 days of
April 30, 2015
.
|
|
(8)
|
Includes: (a)
25,000
shares of Common Stock, directly held by Mr. Ghoniem, and (b) options to purchase
25,000
shares of Common Stock exercisable within 60 days of
April 30, 2015
.
|
|
(9)
|
Includes: (a)
8,500
shares of Common Stock, directly held by Mr. Garrison, and (b) options to purchase
12,500
shares of Common Stock exercisable within 60 days of
April 30, 2015
.
|
|
(10)
|
Includes: options to purchase
18,750
shares of Common Stock exercisable within 60 days of
April 30, 2015
.
|
|
(11)
|
Includes: options to purchase
6,250
shares of Common Stock exercisable within 60 days of
April 30, 2015
.
|
|
|
|
Number of securities to be issued upon exercise of outstanding options, warrants and rights
|
|
Weighted-average exercise price of outstanding options, warrants and rights
|
|
Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in second column)
|
||||
|
Equity compensation plans approved by security holders
|
|
1,356,325
|
|
|
$
|
2.77
|
|
|
1,748,783
|
|
|
Equity compensation plans not approved by security holders
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
Total
|
|
1,356,325
|
|
|
$
|
2.77
|
|
|
1,748,783
|
|
|
Name and principal position
|
Year
|
Salary ($)
|
Bonus ($)
|
Stock awards ($)
|
Option awards ($)(1)
|
All other compensation ($)
|
Total ($)
|
||||||
|
John N. Hatsopoulos
|
2014
|
1
|
|
—
|
|
—
|
|
—
|
|
—
|
|
1
|
|
|
Co-Chief Executive Officer
|
2013
|
1
|
|
—
|
|
—
|
|
—
|
|
—
|
|
1
|
|
|
(Principal Executive Officer)
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
||||||
|
Benjamin Locke
|
2014
|
150,000
|
|
—
|
|
—
|
|
323,751
|
|
—
|
|
473,751
|
|
|
Co-Chief Executive Officer
|
2013
|
83,650
|
|
—
|
|
—
|
|
28,284
|
|
—
|
|
111,934
|
|
|
(Principal Executive Officer)
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
||||||
|
Robert A. Panora
|
2014
|
163,770
|
|
50,000
|
|
—
|
|
—
|
|
—
|
|
213,770
|
|
|
Chief Operating Officer and President
|
2013
|
163,770
|
|
—
|
|
—
|
|
—
|
|
—
|
|
163,770
|
|
|
|
|
|
|
|
|
|
|
||||||
|
David A. Garrison
|
2014
|
118,400
|
|
—
|
|
—
|
|
85,387
|
|
—
|
|
203,787
|
|
|
Chief Financial Officer, Treasurer and Secretary
|
|
|
|
|
|
|
|||||||
|
(Principal Financial Officer)
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
||||||
|
Bonnie J. Brown
(2)
|
2014
|
120,840
|
|
—
|
|
—
|
|
—
|
|
21,800
|
|
142,640
|
|
|
Former Chief Financial Officer, Treasurer and Secretary
|
2013
|
156,000
|
|
—
|
|
—
|
|
—
|
|
—
|
|
156,000
|
|
|
(1)
|
The amounts in the “Stock Option Awards” column reflect the aggregate grant date fair value of the awards computed in accordance with FASB ASC Topic 718. The assumptions used by us with respect to the valuation of stock and option awards are set forth in Note 10 – Stockholders’ equity to our 2014 Annual Report reported on Form 10-K.
|
|
(2)
|
Ms. Brown resigned as Chief Financial Officer, Treasurer, and Secretary of the Company effective August 15, 2014, and in conjunction with an agreed consulting arrangement severance of $21,800 was paid.
|
|
|
|
Option awards
|
|
Stock awards
|
|||||||||||||
|
Name
|
|
Number of
securities underlying unexercised options (#)exercisable |
|
Number of
securities underlying unexercised options (#)unexercisable |
|
Option
exercise
price ($)
|
|
Option
expiration
date
|
|
Number of
shares of stock that have
not vested (#)
|
|
Market value
of shares of stock that have
not vested ($)
(1)
|
|||||
|
John N. Hatsopoulos
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
—
|
|
|
—
|
|
|
Benjamin M. Locke
(2)(3)(4)
|
|
9,375
|
|
|
28,125
|
|
|
3.20
|
|
|
6/3/2023
|
|
|
|
|
|
|
|
|
|
—
|
|
|
62,500
|
|
|
4.96
|
|
|
12/18/2024
|
|
|
|
|
|
|
|
|
|
—
|
|
|
100,000
|
|
|
4.96
|
|
|
12/18/2024
|
|
|
|
|
|
|
|
Robert A. Panora
(5)
|
|
93,750
|
|
|
31,250
|
|
|
2.60
|
|
|
2/14/2021
|
|
138,350
|
|
|
722,187
|
|
|
David A. Garrison
(6)
|
|
6,250
|
|
|
18,750
|
|
|
4.50
|
|
|
4/24/2024
|
|
|
|
|
|
|
|
(1)
|
Market value of shares of stock that have not vested is computed based on the closing price of the Company’s Common Stock on December 31, 2014, which was $
5.22
per share.
|
|
(2)
|
Includes stock option award granted on June 3, 2013, with 25% of the shares vesting on June 3, 2014 and then an additional 25% of the shares vesting on each of the subsequent three anniversaries, subject to Mr. Locke’s continued employment and subject to acceleration of vesting upon a change in control.
|
|
(3)
|
Includes stock option award granted on December 18, 2014, with 25% of the shares vesting on December 18, 2015 and then an additional 25% of the shares vesting on each of the subsequent three anniversaries, subject to Mr. Locke’s continued employment and subject to acceleration of vesting upon a change in control.
|
|
(4)
|
Includes stock option award granted on December 18, 2014, with the shares vesting if the Company achieves a positive adjusted EBITDA for the year ended 2015, subject to Mr. Locke’s continued employment and subject to acceleration of vesting upon a change in control.
|
|
(5)
|
Includes stock option award granted on February 15, 2011, with 25% of the shares vesting on February 15, 2012 and then an additional 25% of the shares vesting on each of the subsequent three anniversaries, subject to Mr. Panora’s continued employment and subject to acceleration of vesting upon a change in control. Includes 138,350 shares of restricted Common Stock at a purchase price of $.001 per share granted on December 4, 2006, with 100% of the shares vesting one year after the Company’s initial public offering, subject to acceleration of vesting upon a change in control prior to a termination event.
|
|
(6)
|
Includes stock option award granted on April 25, 2014, with 25% of the shares vesting on April 25, 2015 and then an additional 25% of the shares vesting on each of the subsequent three anniversaries, subject to Ms. Garrison’s continued employment and subject to acceleration of vesting upon a change in control.
|
|
Name
|
Fees earned or paid in cash ($)
|
Stock awards ($)
|
Option awards ($)
|
All other compensation ($)
|
Total ($)
|
|||||
|
Angelina M. Galiteva
|
4,500
|
|
—
|
|
—
|
|
—
|
|
4,500
|
|
|
Joseph E. Aoun
|
2,500
|
|
—
|
|
—
|
|
—
|
|
2,500
|
|
|
Ahmed F. Ghoniem
|
2,500
|
|
—
|
|
—
|
|
—
|
|
2,500
|
|
|
Charles T. Maxwell
|
2,500
|
|
—
|
|
—
|
|
—
|
|
2,500
|
|
|
Earl R. Lewis
|
500
|
|
42,176
|
|
—
|
|
—
|
|
42,676
|
|
|
|
|
Option awards
|
|
Stock awards
|
|||||||||||||
|
Name
|
|
Number of
securities underlying unexercised options (#)exercisable |
|
Number of
securities
underlying
unexercised
options (#)
unexercisable
|
|
Option
exercise
price ($)
|
|
Option
expiration
date
|
|
Number of
shares of stock that have
not vested (#)
|
|
Market value
of shares of stock that have not vested ($) |
|||||
|
Angelina M. Galiteva
(1)
|
|
25,000
|
|
|
—
|
|
|
2.60
|
|
|
2/14/2021
|
|
25,000
|
|
|
130,500
|
|
|
Joseph E. Aoun
(2)
|
|
6,250
|
|
|
18,750
|
|
|
5
|
|
|
12/31/2023
|
|
|
|
|
|
|
|
Ahmed F. Ghoniem
(3)
|
|
18,750
|
|
|
6,250
|
|
|
3
|
|
|
2/14/2021
|
|
|
|
|
|
|
|
Earl Lewis
(4)
|
|
—
|
|
|
25,000
|
|
|
4.96
|
|
|
12/18/2024
|
|
|
|
|
|
|
|
Charles T. Maxwell
(5)
|
|
18,750
|
|
|
6,250
|
|
|
2.60
|
|
|
2/14/2021
|
|
|
|
|
|
|
|
(1)
|
Includes stock option award granted on February 15, 2011, with 25% of the shares vesting on February 15, 2012, and then an additional 25% of the shares vesting on each of the subsequent three anniversaries, provided that Ms. Galiteva serves as a director or consultant to the Company. Includes 25,000 shares of restricted Common Stock at a purchase price of $.004 per share granted on December 13, 2006, with 100% of the shares vesting one year after the Company’s initial public offering.
|
|
(2)
|
Includes stock option award granted on December 31, 2013, with 25% of the shares vesting on December 31, 2014, and then an additional 25% of the shares vesting on each of the subsequent three anniversaries, provided that Dr. Aoun serves as a director or consultant to the Company.
|
|
(3)
|
Includes stock option award granted on February 15, 2011, with 25% of the shares vesting on February 15, 2012, and then an additional 25% of the shares vesting on each of the subsequent three anniversaries, provided that Mr. Ghoniem serves as a director or consultant to the Company.
|
|
(4)
|
Includes stock option award granted on December 18, 2014, with 25% of the shares vesting on December 18, 2015, and then an additional 25% of the shares vesting on each of the subsequent three anniversaries, provided that Mr. Lewis serves as a director or consultant to the Company.
|
|
(5)
|
Includes stock option award granted on February 15, 2011, with 25% of the shares vesting on February 15, 2012, and then an additional 25% of the shares vesting on each of the subsequent three anniversaries, provided that Mr. Maxwell serves as a director or consultant to the Company.
|
|
•
|
John N. Hatsopoulos, the Company’s Co-Chief Executive Officer who is also: (a) the Chief Executive Officer and a director of American DG Energy and as of December 31, 2014 holds 19.4% of American DG Energy’s common stock; (b) the Chairman of EuroSite Power and as of December 31, 2014 holds 4.7% of EuroSite Power’s common stock; and (c) a director of Ilios and as of December 31, 2014 holds 7.2% of Ilios’s common stock.
|
|
•
|
Dr. George N. Hatsopoulos, who is John N. Hatsopoulos’ brother, and is also: (a) an investor of American DG Energy and as of December 31, 2014 holds 13.0% of American DG Energy’s common stock; (b) an investor in Eurosite Power and as of December 31, 2014 holds 0.7% of EuroSite Power’s common stock; (c) an investor in Ilios and as of December 31, 2014 holds 3.1% of Ilios's common stock; and (d) was a director of the Company until June 25, 2014.
|
|
(a)
|
a director who is, or during the past three years was, employed by the Company, other than prior employment as an interim executive officer (provided the interim employment did not last longer than one year);
|
|
(b)
|
a director who accepted or has an immediate family member who accepted any compensation from the Company in excess of $120,000 during any period of twelve consecutive months within the three years preceding the determination of independence, other than the following:
|
|
(i)
|
compensation for board or board committee service;
|
|
(ii)
|
compensation paid to an immediate family member who is an employee (other than an executive officer) of the Company;
|
|
(iii)
|
compensation received for former service as an interim executive officer (provided the interim employment did not last longer than one year); or
|
|
(iv)
|
benefits under a tax-qualified retirement plan, or non-discretionary compensation;
|
|
(c)
|
a director who is an immediate family member of an individual who is, or at any time during the past three years was, employed by the Company as an executive officer;
|
|
(d)
|
a director who is, or has an immediate family member who is, a partner in, or a controlling shareholder or an executive officer of, any organization to which the Company made, or from which the Company received, payments (other than those arising solely from investments in the Company's securities or payments under non-discretionary charitable contribution matching programs) that exceed 5% of the organization's consolidated gross revenues for that year, or $200,000, whichever is more, in any of the most recent three fiscal years;
|
|
(e)
|
a director who is, or has an immediate family member who is, employed as an executive officer of another entity where at any time during the most recent three fiscal years any of the issuer's executive officers serve on the compensation committee of such other entity; or
|
|
(f)
|
a director who is, or has an immediate family member who is, a current partner of the Company's outside auditor, or was a partner or employee of the Company's outside auditor who worked on the Company's audit at any time during any of the past three years.
|
|
|
2014
|
|
|
Audit fees
|
$107,100
|
|
|
Audit-related fees
|
—
|
|
|
Tax fees
|
—
|
|
|
All other fees
|
—
|
|
|
Total
|
$107,100
|
|
|
|
|
2014
|
|
2013
|
||
|
Audit fees
|
|
$90,400
|
|
$137,000
|
||
|
Audit-related fees
(1)
|
|
120,600
|
|
|
101,100
|
|
|
Tax fees
|
|
—
|
|
|
—
|
|
|
All other fees
|
|
—
|
|
|
—
|
|
|
Total
|
|
$211,000
|
|
$238,100
|
||
|
1.
|
To elect six (6) directors of the Board of Directors of the Company to hold office for one (1) year until the 2016 annual meeting or until their successors are duly elected and qualified:
|
|
2.
|
To approve the non-binding advisory proposal regarding executive compensation.
|
|
3.
|
To approve the non-binding, advisory vote on the frequency of future advisory votes on the Company's executive compensation.
|
|
4.
|
To ratify the selection by the Audit Committee of our Board of Directors of the firm of Wolf and Co., as our independent registered public accounting firm for the fiscal year ending December 31, 2015.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|